C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings

Patents for C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings (34,408)
10/2002
10/31/2002	WO2002085838A1 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds
10/31/2002	WO2002048072A3 Organic reactions with co generating materials
10/31/2002	WO2002026720A3 PIPERAZINE BASED INHIBITORS OF FACTOR Xa
10/31/2002	WO2002020493A3 A traceless solid-phase synthesis of 2-imidazolones
10/31/2002	WO2001058855A9 Use of androgen receptor suppressors
10/31/2002	WO2001053331A9 Peptidomimetic modulators of cell adhesion
10/31/2002	US20020161261 Ionic liquids and production and use thereof
10/31/2002	US20020161237 (Z)-2-((2-bromo-4-(((3-hydroxybenzyl)amino)carbonyl)benzoyl) -amino)pent-2-enoic acid, for example; useful for treating psoriasis
10/31/2002	US20020161224 Diaryl ethers and processes for their preparation and herbicidal and desiccant compositions containing them
10/31/2002	US20020161206 For inhibiting tumor cell growth
10/31/2002	US20020161031 For example, 2-((2-bromo-3-chloro-5-dimethylamino-6-methylphenyl)imino)imid azolidine
10/31/2002	US20020161011 Potassium channel inhibitors
10/31/2002	US20020160993 Method for treating glaucoma IC
10/30/2002	EP1253469A1 Photographic element containing imidazolonoylacetanilide coupler
10/30/2002	EP1253142A1 Compounds exhibiting thrombopoietin receptor agonism
10/30/2002	EP1252154A1 Heterocyclic amide derivatives
10/30/2002	EP0854863B1 Esters and amides as pla2 inhibitors
10/30/2002	CN1377336A Carboxylic acid derivatives and drugs containing the same
10/30/2002	CN1377259A ACE-2 inhibiting compounds and methods of use thereof
10/30/2002	CN1376671A Method for preparing methylthioamino acid or alkali salts thereof
10/30/2002	CN1093536C 5-lipoxygenase inhibitor
10/30/2002	CN1093535C Imiazole derivative
10/29/2002	US6472562 N-guanidinoalkylamides, their preparation, their use, and pharmaceutical preparations comprising them
10/29/2002	US6472537 Polyamides for binding in the minor groove of double stranded DNA
10/29/2002	US6472536 Such as 2-(4-(4-cyclopentyloxybenzyl)phenyl)amino-imidazoline; antinociceptive agents; ip receptor antagonists; treating inflammatory pain
10/29/2002	US6472529 Viricides
10/29/2002	US6472415 Androgen receptor suppressors in the therapy and diagnosis of prostate cancer, alopecia and other hyper-androgenic syndromes
10/29/2002	US6472414 Conformationally restricted aromatic inhibitors of microsomal triglyceride transfer protein and method
10/29/2002	US6472407 α and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
10/29/2002	US6472388 Psychotherapeutic agents.
10/29/2002	US6472386 Cyclic diamine compound with 5-membered ring groups
10/29/2002	CA2158763C Novel process for preparation of clonidine derivatives
10/24/2002	WO2002083716A2 Type b botulism toxin inhibitors
10/24/2002	WO2002083656A2 5-membered heterocycles, preparation and use thereof as mao inhibitors and lipid peroxidation inhibitors, preparation thereof and use thereof as medicaments
10/24/2002	WO2002083649A1 Novel imidazolidinedione derivatives and use thereof as drugs
10/24/2002	WO2002083622A2 Novel aminophenyl ketone derivatives
10/24/2002	WO2002083133A1 Novel oral general anesthetics and metabolitically resistant anticonvulsants
10/24/2002	WO2002083111A2 Imidazole, thiazole and oxazole derivatives and their use for the manufacture of a medicament for the treatment and/or prevention of pollakiuria or urinary incontinence
10/24/2002	WO2002083067A2 Prodrugs via acylation with cinnamate
10/24/2002	WO2002022626A8 Combretastatin a-4 phosphate prodrug salts with nitrogen-containing compounds
10/24/2002	US20020156291 Rockets; propullants
10/24/2002	US20020156113 Farnesyl transferase inhibitors; anticancer agents
10/24/2002	US20020156082 Compounds having activity as inhibitors of cytochrome P450RAI
10/24/2002	US20020156076 Imidazole derivatives used to reduce ocular pressure or treat glaucoma and other diseases
10/24/2002	CA2444596A1 Large conductance calcium-activated k channel opener
10/24/2002	CA2444264A1 Prodrugs via acylation with cinnamate
10/24/2002	CA2443906A1 Novel oral general anesthetics and metabolitically resistant anticonvulsants
10/24/2002	CA2443811A1 Type b botulism toxin inhibitors
10/23/2002	EP1250335A2 Process and intermediates for the preparation of imidazopyridines
10/23/2002	EP1250327A2 Process for producing n-halogenated organic compounds
10/23/2002	EP1250293A1 Production of compacted biocidal agent from a non-compactible particulate biocidal agent without using a binder
10/23/2002	EP1250049A1 1,3-dibromo-5,5-dimethylhydantoin of enhanced properties
10/23/2002	EP1196384A4 1-(aromatic- or heteroaromatic-substituted)-3-(heteroaromatic substituted)-1,3-propanediones and uses thereof
10/23/2002	EP1105449A4 Amphoteric derivatives of aliphatic polyamines with fatty acids, esters or triglycerides
10/23/2002	CN1376155A Thiourea and isothiourea derivatives for inhibiting RAS-transformed cell growth
10/23/2002	CN1376153A Amide compounds
10/23/2002	CN1376146A Solid-state form of celecoxil having enhanced bioavailability
10/23/2002	CN1375491A 酯交换方法 Transesterification method
10/23/2002	CN1093128C Process for preparing eprosartan
10/23/2002	CN1093124C Substituted 4-hydroxy-phenylalcanoic acid derivatives with agonist activity to PPAR-gamma
10/23/2002	CN1093123C Aralkyl and aralkylidene heterocyclic lactams and imides
10/22/2002	US6469207 Hiv protease inhibitors; administering to treat aids (acquired immune deficiency syndrome)
10/22/2002	US6469178 Conversion of hydroxymethyl imidazoles to formylimidazoles in the presence of a peroxide using a noble metal catalyst.
10/22/2002	US6469065 Compound that donates, transfers or releases nitric oxide, elevates endogenous levels of nitric oxide
10/22/2002	US6469002 Compounds which modulate chemokine receptor activity and are useful in treatment of inflammatory diseases
10/22/2002	US6469000 1,3-diheterocyclic metalloprotease inhibitors
10/22/2002	US6468989 Gel compositions containing metronidazole
10/22/2002	US6468316 Direct dyes having colorfastness and solubility, used for human hair
10/17/2002	WO2002081483A2 Inhibitors of acyl glucosaminyl inositol amidase and methods of use
10/17/2002	WO2002081453A1 Thiohydantoins and use thereof for treating diabetes
10/17/2002	WO2002081435A1 Sulphones which modulate the action of gamma secretase
10/17/2002	WO2002081433A1 Sulphones which modulate the action of gamma secretase
10/17/2002	WO2002080869A2 Novel dyeing composition for dyeing keratinous fibres comprising a particular dicationic monoazo dye
10/17/2002	WO2002067053A3 High speed photothermographic materials containing tellurium compounds and methods of using same
10/17/2002	WO2002062301A3 Method and composition for rejuvinating cells, tissues, organs, hair and nails
10/17/2002	WO2001041760A8 Cyclooxygenase-2 inhibitor compositions having rapid onset of therapeutic effect
10/17/2002	US20020151744 Kinetic resolutions of chiral 2-and-3-substituted carboxylic acids
10/17/2002	US20020151715 Imidazole derivatives
10/17/2002	US20020151529 Bile-acid derived compounds for providing sustained systemic concentrations of drugs after oral administration
10/17/2002	US20020148052 Such as 4-amino-2-(2-dimethylamino-ethyl)-phenol; useful in place of p-aminophenol
10/17/2002	CA2444024A1 Thiohydantoins and use thereof for treating diabetes
10/16/2002	EP1249233A1 Npyy5 antagonists
10/16/2002	EP1248625A2 Use of methylol-containing compounds for the manufacture of a medicament for the treatment of tumors
10/16/2002	EP1248615A1 Thiazole, imidazole and oxazole compounds and treatments of disorders associated with protein aging
10/16/2002	EP1248612A1 Novel compounds and compositions as protease inhibitors
10/16/2002	EP0641203B1 Pharmaceutical compositions of an imidazolyl-akenoic acid salt and their use as angiotensin ii antagonists
10/16/2002	CN1375103A Process for recycling ionic liquids
10/16/2002	CN1374951A Process for the preparation of 4(5)-amino-5(4) carboxamidoimidazoles and intermediates thereof
10/16/2002	CN1374298A Sulfenylation process of pyrozole compound with trifluoromethanesulfonyl radical
10/16/2002	CN1092645C Prevention/remedies for complication of diabetes
10/16/2002	CN1092644C 4-methylimidazole refining process
10/16/2002	CN1092643C Certain aminomethyl phenylidazole derivatives, for intensifying memory
10/15/2002	US6465680 Process for preparing malonate derivatives or β-keto esters from epoxide derivatives
10/15/2002	US6465658 Reacting azolide salts with phosgene in an aromatic compound or an ether as solvent
10/15/2002	US6465650 Intermediate steps in preparing peptide nucleic acids
10/15/2002	US6465474 Treatment of such as osteoarthitis, rheumatoid arthritis, prevention or arrest of tumor growth and metastasis, corneal ulceration, lack of corneal healing, macular degeneration, periodontal disease, gingivitis
10/15/2002	US6464731 Cationic monobenzene nitrophenylenediamines, their use in dyeing keratinous fibers, dyeing compositions comprising them and dyeing processes
10/15/2002	CA2112690C Amino acid derivative
10/15/2002	CA2066943C Heterocyclically substituted phenylacetic acid derivatives, processes for their preparation and their use in medicaments
10/10/2002	WO2002079168A1 Imidazolyl derivatives useful as histamine h3 receptor ligands

1 ... 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 ... 345